ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,881.60
0.18%
Dow Jones
40,211.72
0.53%
Brent Oil
83.385
-1.13%
Bitcoin
63,440.89
-2.19%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) News

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
02/08/20244:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
01/19/20244:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INABIN8bio Inc
01/19/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INABIN8bio Inc
01/18/20244:31PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INABIN8bio Inc
01/12/20245:16PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INABIN8bio Inc
01/04/20248:00AMGlobeNewswire Inc.IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline GoalsNASDAQ:INABIN8bio Inc
12/28/202312:28PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INABIN8bio Inc
12/15/20234:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INABIN8bio Inc
12/15/20238:27AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20238:26AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20238:24AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20238:23AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20238:22AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20238:20AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20238:19AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/15/20236:02AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/14/20236:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/11/20235:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
12/11/20234:05PMGlobeNewswire Inc.IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in LeukemiaNASDAQ:INABIN8bio Inc
12/11/20239:00AMGlobeNewswire Inc.IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private PlacementNASDAQ:INABIN8bio Inc
12/11/20238:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
12/08/20234:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/08/20234:24PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/07/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
12/07/20238:00AMGlobeNewswire Inc.IN8bio Appoints Dr. Corinne Epperly to Board of DirectorsNASDAQ:INABIN8bio Inc
12/05/20238:00AMGlobeNewswire Inc.IN8bio to Host Investor Call at 8:30 AM ET on Tuesday, December 12 to Discuss Updated Clinical Data from Phase 1 Trial of INB-100 in Patients with LeukemiaNASDAQ:INABIN8bio Inc
11/20/20239:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
11/20/20237:00AMGlobeNewswire Inc.IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed GlioblastomaNASDAQ:INABIN8bio Inc
11/10/20237:00AMGlobeNewswire Inc.IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual MeetingNASDAQ:INABIN8bio Inc
11/09/20234:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

LSE
78GL
Caffyns 7%pf
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved